By Dr Therese Maria Becker

Book Chapters

Po JW; Ma Y; Balakrishnar B; Brungs D; Azimi F; Cooper A; Saricilar E; Murthy V; de Souza P; Becker TM, 2021, 'PD-L1 Detection on Circulating Melanoma Cells', in Melanoma: Methods and Protocols, pp. 223 - 233, http://dx.doi.org/10.1007/978-1-0716-1205-7_17

Po JW; Ma Y; Luk AWS; Lynch D; Balakrishnar B; Brungs D; Azimi F; Cooper A; Saricilar E; Murthy V; de Souza P; Becker TM, 2021, 'Single-Cell Analysis of BRAF^V600E and NRAS^Q61R Mutation Status in Melanoma Cell Lines as Method Generation for Circulating Melanoma Cells', in Melanoma: Methods and Protocols, pp. 277 - 286, http://dx.doi.org/10.1007/978-1-0716-1205-7_21

Po JW; Lynch D; de Souza P; Becker TM, 2016, 'Importance and Detection of Epithelial-to-Mesenchymal Transition (EMT) Phenotype in CTCs', in Xu K (ed.), TUMOR METASTASIS, INTECH EUROPE, pp. 241 - 256, http://dx.doi.org/10.5772/64342

Becker T; Haferkamp S, 2013, 'Molecular Mechanisms of Cellular Senescence', in Senescence and Senescence-Related Disorders, InTech, http://dx.doi.org/10.5772/54120

Rizos H; Becker T; Holland E, 2003, 'Cell cycle regulation in the melanocyte', in Textbook of Melanoma, CRC Press, pp. 13 - 24, http://dx.doi.org/10.1201/b14732-3

Becker TM; Rizos H, 2003, 'Regulation of Cellular Senescence by the Retinoblastoma Pathway', in Aging of Cells in and Outside the Body, Springer Netherlands, pp. 151 - 169, http://dx.doi.org/10.1007/978-94-017-0669-8_9

Journal articles

Hirani R; Ross B; Ma Y; Irish K; Chamberlain J; Becker T; Smalley A; Irving H; Irving DO, 2024, 'The incidence of donor white blood cell survival (transfusion-associated microchimerism) in Australian pediatric patients', Transfusion, 64, pp. 1830 - 1840, http://dx.doi.org/10.1111/trf.18010

Chan WY; Chua W; Wilkinson K; Epitakaduwa C; Mandaliya H; Descallar J; Roberts TL; Becker TM; Ng W; Lee CS; Lim SHS, 2024, 'The Prognostic and Predictive Utility of CDX2 in Colorectal Cancer', International Journal of Molecular Sciences, 25, http://dx.doi.org/10.3390/ijms25168673

Nindra U; Lin P; Becker T; Roberts TL; Chua W, 2024, 'Current state of theranostics in metastatic castrate-resistant prostate cancer', Journal of Medical Imaging and Radiation Oncology, 68, pp. 412 - 420, http://dx.doi.org/10.1111/1754-9485.13658

Lea V; Lim SH-S; Chua W; Ng WL; Wang B; Wilkinson KJ; Farzin M; Habashy P; Roberts T; Becker T; Lee CS, 2024, 'Incidence and potential prognostic implications of fibroblast growth factor receptor gene alterations and coexisting mutations in colorectal cancer.', Journal of Clinical Oncology, 42, pp. e15558 - e15558, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e15558

Ho V; Chung L; Wilkinson K; Ma Y; Rutland T; Lea V; Lim SH; Abubakar A; Ng W; Lee M; Roberts TL; Becker TM; Mackenzie S; Chua W; Lee CS, 2024, 'Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer', Cancers, 16, http://dx.doi.org/10.3390/cancers16112005

Nindra U; Pal A; Bray V; Yip PY; Tognela A; Roberts TL; Becker TM; Williamson J; Farzin M; Li JJ; Lea V; Hagelamin A; Ng W; Wang B; Lee CS; Chua W, 2024, 'Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer', Internal Medicine Journal, 54, pp. 596 - 601, http://dx.doi.org/10.1111/imj.16224

El-Kamand S; Quinn JMW; Sareen H; Becker TM; Wong-Erasmus M; Cowley MJ, 2024, 'CRUX, a platform for visualising, exploring and analysing cancer genome cohort data', NAR Genomics and Bioinformatics, 6, http://dx.doi.org/10.1093/nargab/lqae003

Habashy P; Lea V; Wilkinson K; Wang B; Wu XJ; Roberts TL; Ng W; Rutland T; Po JW; Becker T; Descallar J; Lee M; Mackenzie S; Gupta R; Cooper W; Lim S; Chua W; Lee CS, 2023, 'KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms242417509

Grebstad Tune B; Sareen H; Powter B; Kahana-Edwin S; Cooper A; Koh ES; Lee CS; Po JW; McCowage G; Dexter M; Cain L; O’Neill G; Prior V; Karpelowsky J; Tsoli M; Baumbusch LO; Ziegler D; Roberts TL; DeSouza P; Becker TM; Ma Y, 2023, 'From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients', Biomedicines, 11, http://dx.doi.org/10.3390/biomedicines11112907

Davoudi F; Moradi A; Becker TM; Lock JG; Abbey B; Fontanarosa D; Haworth A; Clements J; Ecker RC; Batra J, 2023, 'Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer', Current Treatment Options in Oncology, 24, pp. 1451 - 1471, http://dx.doi.org/10.1007/s11864-023-01121-z

Nindra U; Pal A; Lea V; Lim SHS; Wilkinson K; Asghari R; Roberts TL; Becker TM; Farzin M; Rutland T; Lee M; MacKenzie S; Ng W; Wang B; Soon Lee C; Chua W, 2023, 'Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0292087

Marivel AMJ; Ma Y; Becker TM; Verma A; Trieu S; Roberts TL; Ling SCW, 2023, 'The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma', Leukemia Research Reports, 20, pp. 100393, http://dx.doi.org/10.1016/j.lrr.2023.100393

Khan T; Lock JG; Ma Y; Harman DG; de Souza P; Chua W; Balakrishnar B; Scott KF; Becker TM, 2022, 'Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-20079-w

Tincknell G; Naveed A; Nankervis J; Mukhtiar A; Piper AK; Becker TM; Chantrill L; Aghmesheh M; Vine KL; Ranson M; Brungs D, 2022, 'HER2-Positive Gastroesophageal Cancers Are Associated with a Higher Risk of Brain Metastasis', Cancers, 14, http://dx.doi.org/10.3390/cancers14235754

Woodford R; Brungs D; Leighton C; Grimison P; Sjoquist KM; Becker T; Robinson S; Gebski V; Wilson K; Chantrill L; Aghmesheh M, 2022, 'Combination chemotherapy with NAB^®-paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP-CAPABIL Pilot Study)', Asia-Pacific Journal of Clinical Oncology, 18, pp. e220 - e226, http://dx.doi.org/10.1111/ajco.13599

, 2022, 'Towards Diagnostic ctDNA Testing in Multiple Myeloma: How does Automated Magnetic Bead-Based Cell-Free DNA Extraction Compare to the Leading Silica Membrane-Based Manual Extraction?', Biomarkers and Applications, 5, http://dx.doi.org/10.29011/2576-9588.100043

Sareen H; Ma Y; Becker TM; Roberts TL; de Souza P; Powter B, 2022, 'Molecular Biomarkers in Glioblastoma: A Systematic Review and Meta-Analysis', International journal of molecular sciences, 23, http://dx.doi.org/10.3390/ijms23168835

Khan T; Becker TM; Po JW; Chua W; Ma Y, 2022, 'Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers', International Journal of Molecular Sciences, 23, http://dx.doi.org/10.3390/ijms23158386

Jeffreys SA; Becker TM; Khan S; Soon P; Neubauer H; de Souza P; Powter B, 2022, 'Prognostic and Predictive Value of CCND1/Cyclin D1 Amplification in Breast Cancer With a Focus on Postmenopausal Patients: A Systematic Review and Meta-Analysis', Frontiers in Endocrinology, 13, http://dx.doi.org/10.3389/fendo.2022.895729

Fatima S; Ma Y; Safrachi A; Haider S; Spring KJ; Vafaee F; Scott KF; Roberts TL; Becker TM; de Souza P, 2022, 'Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy', Cancers, 14, http://dx.doi.org/10.3390/cancers14071669

Yeap I; Becker T; Azimi F; Kernohan M, 2022, 'The management of hereditary melanoma, FAMMM syndrome and germline CDKN2A mutations: a narrative review', Australasian Journal of Plastic Surgery, 5, pp. 12 - 22, http://dx.doi.org/10.34239/ajops.v5n2.324

Khan T; Becker TM; Scott KF; Descallar J; de Souza P; Chua W; Ma Y, 2022, 'Prognostic and Predictive Value of Liquid Biopsy-Derived Androgen Receptor Variant 7 (AR-V7) in Prostate Cancer: A Systematic Review and Meta-Analysis', Frontiers in Oncology, 12, http://dx.doi.org/10.3389/fonc.2022.868031

Young FP; Becker TM; Nimir M; Opperman T; Chua W; Balakrishnar B; de Souza P; Ma Y, 2022, 'Biomarkers of Castrate Resistance in Prostate Cancer: Androgen Receptor Amplification and T877A Mutation Detection by Multiplex Droplet Digital PCR', Journal of Clinical Medicine, 11, http://dx.doi.org/10.3390/jcm11010257

Wilkinson K; Ng W; Roberts TL; Becker TM; Lim SHS; Chua W; Lee CS, 2021, 'Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer', Journal of Clinical Pathology, 74, pp. 625 - 634, http://dx.doi.org/10.1136/jclinpath-2020-207309

Tincknell G; Piper AK; Aghmesheh M; Becker T; Vine KL; Brungs D; Ranson M, 2021, 'Experimental and clinical evidence supports the use of urokinase plasminogen activation system components as clinically relevant biomarkers in gastroesophageal adenocarcinoma', Cancers, 13, http://dx.doi.org/10.3390/cancers13164097

Garrett C; Becker TM; Lynch D; Po J; Xuan W; Scott KF; De Souza P, 2021, 'Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome', PLoS ONE, 16, http://dx.doi.org/10.1371/journal.pone.0252614

Pang TCY; Xu Z; Mekapogu AR; Pothula S; Becker T; Corley S; Wilkins MR; Goldstein D; Pirola R; Wilson J; Apte M, 2021, 'Hgf/c-met inhibition as adjuvant therapy improves outcomes in an orthotopic mouse model of pancreatic cancer', Cancers, 13, pp. 2763, http://dx.doi.org/10.3390/cancers13112763

Powter B; Jeffreys SA; Sareen H; Cooper A; Brungs D; Po J; Roberts T; Koh ES; Scott KF; Sajinovic M; Vessey JY; de Souza P; Becker TM, 2021, 'Human TERT promoter mutations as a prognostic biomarker in glioma', Journal of Cancer Research and Clinical Oncology, 147, pp. 1007 - 1017, http://dx.doi.org/10.1007/s00432-021-03536-3

Ding PN; Roberts TL; Chua W; Becker TM; Caixeiro N; de Souza P; Gao B; Lee CK; Itchins M; Westman H; Clarke S; Blinman P; Kao S; John T; Leal JL; Bray VJ, 2021, 'Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinib', Translational Lung Cancer Research, 10, pp. 1623 - 1634, http://dx.doi.org/10.21037/tlcr-20-1125

Adam T; Becker TM; Chua W; Bray V; Roberts TL, 2021, 'The multiple potential biomarkers for predicting immunotherapy response-finding the needle in the haystack', Cancers, 13, pp. 1 - 20, http://dx.doi.org/10.3390/cancers13020277

Pang TCY; Po JW; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2021, 'Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications', Pancreatology, 21, pp. 103 - 114, http://dx.doi.org/10.1016/j.pan.2020.11.022

Brungs D; Minaei E; Piper AK; Perry J; Splitt A; Carolan M; Ryan S; Wu XJ; Corde S; Tehei M; Aghmesheh M; Vine KL; Becker TM; Ranson M, 2020, 'Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer', Scientific Reports, 10, http://dx.doi.org/10.1038/s41598-019-57164-6

Pang TCY; Xu Z; Mekapogu AR; Pothula S; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2020, 'An Orthotopic Resectional Mouse Model of Pancreatic Cancer', Journal of Visualized Experiments, http://dx.doi.org/10.3791/61726-v

Pang TCY; Xu Z; Mekapogu AR; Pothula S; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2020, 'An orthotopic resectional mouse model of pancreatic cancer', Journal of Visualized Experiments, 2020, pp. 1 - 13, http://dx.doi.org/10.3791/61726

Jeffreys SA; Powter B; Balakrishnar B; Mok K; Soon P; Franken A; Neubauer H; Souza PD; Becker TM, 2020, 'Endocrine resistance in breast cancer: The role of estrogen receptor stability', Cells, 9, pp. 1 - 23, http://dx.doi.org/10.3390/cells9092077

Sareen H; Garrett C; Lynch D; Powter B; Brungs D; Cooper A; Po J; Koh ES; Vessey JY; McKechnie S; Bazina R; Sheridan M; van Gelder J; Darwish B; Jaeger M; Roberts TL; De Souza P; Becker TM, 2020, 'The role of liquid biopsies in detecting molecular tumor biomarkers in brain cancer patients', Cancers, 12, pp. 1 - 16, http://dx.doi.org/10.3390/cancers12071831

Lynch D; Powter B; Po JW; Cooper A; Garrett C; Koh ES; Sheridan M; van Gelder J; Darwish B; Mckechnie S; Bazina R; Jaeger M; Roberts TL; de Souza P; Becker TM, 2020, 'Isolation of circulating tumor cells from glioblastoma patients by direct immunomagnetic targeting', Applied Sciences (Switzerland), 10, http://dx.doi.org/10.3390/app10093338

Khan T; Scott KF; Becker TM; Lock J; Nimir M; Ma Y; De Souza P, 2020, 'The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?', Prostate Cancer, 2020, http://dx.doi.org/10.1155/2020/7938280

Ding PN; Becker T; Bray V; Chua W; Ma Y; Xu B; Lynch D; de Souza P; Roberts T, 2019, 'Plasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimertinib', Thoracic Cancer, 10, pp. 1879 - 1884, http://dx.doi.org/10.1111/1759-7714.13154

Brungs D; Lochhead A; Iyer A; Illemann M; Colligan P; Hirst NG; Splitt A; Liauw W; Vine KL; Pathmanandavel S; Carolan M; Becker TM; Aghmesheh M; Ranson M, 2019, 'Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma', Pathology, 51, pp. 474 - 480, http://dx.doi.org/10.1016/j.pathol.2019.03.009

Ding PN; Becker TM; Bray VJ; Chua W; Ma YF; Lynch D; Po J; Luk AWS; Caixeiro N; de Souza P; Roberts TL, 2019, 'The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study', Lung Cancer, 134, pp. 187 - 193, http://dx.doi.org/10.1016/j.lungcan.2019.06.021

Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; Souza PD; Becker TM, 2019, 'Detection of AR-v7 in liquid biopsies of castrate resistant prostate cancer patients: A comparison of AR-v7 analysis in circulating tumor cells, circulating tumor RNA and exosomes', Cells, 8, http://dx.doi.org/10.3390/cells8070688

Po JW; Ma Y; Balakrishna B; Brungs D; Azimi F; De Souza P; Becker TM, 2019, 'Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status', PLoS ONE, 14, http://dx.doi.org/10.1371/journal.pone.0211866

Singh P; de Souza P; Scott KF; Hall BM; Verma ND; Becker TM; Toh JWT; Sajinovic M; Spring KJ, 2019, 'Biomarkers in immune checkpoint inhibition therapy for cancer patients: what is the role of lymphocyte subsets and PD1/PD-L1?', Translational Medicine Communications, 4, http://dx.doi.org/10.1186/s41231-019-0032-9

Back to profile page